Category: New products
-
Trial Shows Gut Probiotic Reduces Covid-19 Disease
Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease.
-
Biotech, AI Company Partner on Covid-19 Alert System
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants.
-
AI Pharma Company Raises $15M in Early Funds
A company using algorithms to develop new drugs designed to better succeed in clinical trials is raising $15 million in its first venture round.
-
Trial Set for Covid-19 Nasal Spray Vaccine
A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands.
-
Optogenetics Start-Up Raises $6M for Retinal Therapy
A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds.
-
Bio-Based Material Shown to Aid Tendon Repair
Academic and industry researchers demonstrated in lab animals a tough material derived from natural sources that speeds repair of injured tendons.
-
Trial Underway Testing PTSD Drug Therapy
A clinical trial is underway testing an experimental drug to treat the underlying causes and symptoms of post-traumatic stress disorder or PTSD.
-
India Authorizes Covid-19 Vaccines Designed in US
The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs.
-
Device Spin-Off Raises $2.2M in Seed Funds
A medical technology company developing a sensor device that monitors catheters draining excess brain fluid is raising $2.2 million in seed funds.
-
FDA Clears Rapid At-Home Covid-19 Test
The Food and Drug Administration granted an emergency authorization to a quick diagnostic test for SARS-CoV-2 viruses, conducted at home.